Blastomycosis is a fungal infection caused by the organism Blastomyces dermatitidis. It causes pulmonary infection after the inhalation of spores, and it may be either asymptomatic or have severe life-threatening complications such as acute respiratory distress syndrome. Primary cutaneous blastomycosis, though rare, can occur due to direct inoculation after trauma to the skin. Unlike other deep fungal infections that occur predominantly in immunocompromised patients, blastomycosis occurs in immunocompetent hosts. In infected cells, blastomycosis dermatitidis is seen as budding yeast cells that are relatively large at 8 to 10 micrometers in diameter.
Allied Market Research has published a study report with the title Blastomycosis Market Size was Valued at USD 177.2 million in 2021 and is Projected to Garner USD 257.7 million by 2031 registering a CAGR of 3.8% from 2022 to 2031.
Covid-19 scenario-
- The majority of medical colleges and hospitals were restructured to cater to the Covid-19 patients during the pandemic, which impacted the global blastomycosis market negatively.
- However, as the lockdown relaxations started peeping in, the chances of spreading fungal infection also increased. That’s how the market gradually got back on track.
Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/15998
Top Companies of Blastomycosis: –
- AERCON AAC
- Aerix Industries
- Acico
- Cellular Concrete Inc.
- Cematrix
- Litebuilt Inc.
- Aircrete Europe
- SOLBET
- Xella Group
- Bauroc
Blastomycosis Market Segmentation: –
By Drug Type
- Azoles
- Polyenes
- Others
By Distribution Channel
- Hospital and Clinical Pharmacy
- Online Pharmacy
- Retail Pharmacy
By Formulation
- Tablets
- Ointment
- Powder
- Liquid
By region, the blastomycosis market across North America contributed to more than three-fifths of the global share, and is expected to retain its dominance by 2031. Rise in the number of fungal infection cases and the presence of key players across the region drive the market growth. The LAMEA region, simultaneously, would cite the fastest CAGR of 4.9% from 2022 to 2031. This is attributed to increase in population, rise in the prevalence of immunological diseases such as tuberculosis and HIV diseases, and surge in awareness concerning the use of azoles for the treatment of blastomycosis across the province.
Drivers, restraints, and opportunities-
Rise in diagnostic procedures such as biopsies to detect fungal infection, increase in bone marrow & organ transplantation procedures, and surge in the trend of camping in forests, and favorable government funds to combat antifungal diseases drive the growth of the global blastomycosis market. On the other hand, unfavorable reimbursements as well as complications such as the presence of counterfeit drugs and side effects of blastomycosis drugs restrain the growth to some extent. However, unmet medical demands in developing countries and lucrative opportunities in emerging economies have been beneficial for the industry.
Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/15998
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2031?
- Which region has more opportunities?
By Region Outlook
North America
⦁ U.S.
⦁ Canada
⦁ Mexico
Europe
⦁ UK
⦁ Germany
⦁ France
⦁ Italy
⦁ Russia
⦁ Rest of Europe
Asia-Pacific
⦁ China
⦁ Japan
⦁ India
⦁ Australia
⦁ Rest of Asia-Pacific
LAMEA
⦁ Brazil
⦁ UAE
⦁ Turkey
⦁ Saudi Arabia
⦁ Rest of LAMEA
Top Trending Report:
- Wireless Brain Sensors Market
- Autologous Cell Therapy Market
- Magnetic Resonance Imaging (MRI) Coils Market
- Duchenne Muscular Dystrophy Market
- Toxoplasmosis Treatment Market
Contact Details:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.